Teachey, D T <br/><br/>
Daclizumab for children with corticosteroid refractory graft-versus-host disease.  [electronic resource] 

 -  Bone marrow transplantation  Jan 2006 
 - 95-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705199  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adrenal Cortex Hormones--therapeutic use<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Child<br/>Child, Preschool<br/>Chronic Disease<br/>Daclizumab<br/>Disease-Free Survival<br/>Drug Resistance--drug effects<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Hematologic Diseases--complications<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Infant<br/>Male<br/>Recurrence<br/>Remission Induction<br/>Stem Cell Transplantation<br/>Transplantation, Homologous